i-Ome Discovery protein array

16 May 2024

The i-Ome® Discovery platform from Sengenics offers a high-throughput functional protein array for precise autoantibody profiling, crucial for understanding disease mechanisms and advancing personalized diagnostic and therapeutic approaches in precision medicine. Utilizing KREX® technology for structural preservation of antigens and offering dual isotype detection, i-Ome Discovery enables comprehensive immune response profiling with reduced false discovery rates and smaller sample sizes, facilitating efficient biomarker discovery and clinical application. Sengenics highlights how i-Ome Discovery facilitates the precise identification of autoantibodies for actionable insights. With its expansive array of over 1800 human proteins, the i-Ome Discovery represents a significant advancement in the field of auto-antibody profiling for understanding disease initiation and progression.

Links

Tags